Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hearing loss
Biotech
Lilly strengthens RNA pipeline with $1.3B hearing loss pact
Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal focused on hearing loss.
James Waldron
May 16, 2025 7:34am
Regeneron gene therapy restores hearing in 10 of 11 children
Feb 24, 2025 3:00pm
Pepper chemical prevents hearing loss from powerful antibiotics
Aug 8, 2024 10:40am
Regeneron's 'protein factory' gene therapy restores hearing
May 8, 2024 6:00am
Sensorion's hearing loss drug reaches target in comeback story
Mar 11, 2024 10:35am
Early Lilly data finds gene therapy restores hearing for child
Jan 23, 2024 4:59pm